Follow
Janne J. Turunen
Janne J. Turunen
ProQR Therapeutics
Verified email at proqr.com
Title
Cited by
Cited by
Year
The significant other: splicing by the minor spliceosome
JJ Turunen, EH Niemelä, B Verma, MJ Frilander
Wiley Interdisciplinary Reviews: RNA 4 (1), 61-76, 2013
4152013
Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations
K Dulla, R Slijkerman, HC van Diepen, S Albert, M Dona, W Beumer, ...
Molecular Therapy 29 (8), 2441-2455, 2021
852021
The U11-48K protein contacts the 5′ splice site of U12-type introns and the U11-59K protein
JJ Turunen, CL Will, M Grote, R Lührmann, MJ Frilander
Molecular and Cellular Biology, 2008
522008
Minor spliceosome components are predominantly localized in the nucleus
HKJ Pessa, CL Will, X Meng, C Schneider, NJ Watkins, N Perälä, ...
Proceedings of the National Academy of Sciences 105 (25), 8655-8660, 2008
462008
An ancient mechanism for splicing control: U11 snRNP as an activator of alternative splicing
J Verbeeren, EH Niemelä, JJ Turunen, CL Will, JJ Ravantti, R Lührmann, ...
Molecular cell 37 (6), 821-833, 2010
402010
An ancient mechanism for splicing control: U11 snRNP as an activator of alternative splicing
J Verbeeren, EH Niemelä, JJ Turunen, CL Will, JJ Ravantti, R Lührmann, ...
Molecular cell 37 (6), 821-833, 2010
402010
Agammaglobulinemia: causative mutations and their implications for novel therapies
A Berglöf, JJ Turunen, O Gissberg, B Bestas, KEM Blomberg, CIE Smith
Expert review of clinical immunology 9 (12), 1205-1221, 2013
382013
Micro-minicircle gene therapy: Implications of size on fermentation, complexation, shearing resistance, and expression
S Stenler, OPB Wiklander, M Badal-Tejedor, J Turunen, JZ Nordin, ...
Molecular Therapy—Nucleic Acids 3 (1), e140, 2014
352014
B Cell Receptor Activation Predominantly Regulates AKT-mTORC1/2 Substrates Functionally Related to RNA Processing
DK Mohammad, RH Ali, JJ Turunen, BF Nore, CIE Smith
PloS one 11 (8), e0160255, 2016
342016
HnRNPH1/H2, U1 snRNP, and U11 snRNP cooperate to regulate the stability of the U11-48K pre-mRNA
JJ Turunen, B Verma, TA Nyman, MJ Frilander
RNA 19 (3), 380-389, 2013
302013
Lipid-based Transfection Reagents Exhibit Cryo-induced Increase in Transfection Efficiency
H Sork, JZ Nordin, JJ Turunen, OPB Wiklander, B Bestas, EM Zaghloul, ...
Molecular Therapy—Nucleic Acids 5 (3), e290, 2016
252016
Splice-Correction Strategies for Treatment of X-Linked Agammaglobulinemia
B Bestas, JJ Turunen, KEM Blomberg, Q Wang, R Månsson, ...
Current Allergy and Asthma Reports 15 (3), 1-11, 2015
202015
RNA ligation using T4 DNA ligase
MJ Frilander, JJ Turunen
Handbook of RNA biochemistry, 36-52, 2005
192005
Rational Design of RNA Editing Guide Strands: Cytidine Analogs at the Orphan Position
EE Doherty, XE Wilcox, L van Sint Fiet, C Kemmel, JJ Turunen, B Klein, ...
Journal of the American Chemical Society 143 (18), 6865-6876, 2021
172021
Chemically modified single-stranded RNA-editing oligonucleotides
JJ Turunen, A Aalto, B Klein, LVS Fiet, JAG Boudet
US Patent 10,941,402, 2021
122021
RNA ligation
JJ Turunen, LV Pavlova, M Hengesbach, M Helm, S Müller, RK Hartmann, ...
Handbook of RNA Biochemistry: Second, Completely Revised and Enlarged …, 2014
102014
Single-stranded RNA-editing oligonucleotides
JJ Turunen, PG De Bruijn, B Klein, RS Redis, LVS Fiet
US Patent 10,988,763, 2021
82021
Oligonucleotide complexes for use in RNA editing
A Aalto, JJ Turunen
US Patent 11,274,300, 2022
72022
Handbook of RNA biochemistry.
MJ Frilander, JJ Turunen
Hartmann, RK, Bindereif, A., Schön, A., Westhof, E., Eds, 2005
52005
Antisense oligonucleotides for rna editing
JAG Boudet, LVS Fiet, JJ Turunen
US Patent App. 16/970,193, 2021
42021
The system can't perform the operation now. Try again later.
Articles 1–20